Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Ontario Ministry of Health and Long Term Care
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
Anna Sawka, University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT01083550
First received: February 24, 2010
Last updated: January 5, 2015
Last verified: January 2015